SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-163594 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Syndromic Multiplex Diagnostic Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

7.1 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Luminex Corporation

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 BioFire Diagnostics

16.3 Qiagen

16.4 GenMark Diagnostics

16.5 Binx Health, Inc.

16.6 GenePOC Inc.

16.7 Janssen Global Services, LLC

16.8 Mesa Biotech

16.9 Applied BioCode, Inc.

16.10 Akonni Biosystems, Inc.

16.11 Abbott

16.12 Accelerate Diagnostics, Inc.

16.13 Alveo Technologies

16.14 Hologic, Inc.

16.15 Inflammatix, Inc.

16.16 Bosch Healthcare Solutions GmbH

16.17 Diagenode Diagnostics

16.18 Cepheid

16.19 Bio-Rad Laboratories, Inc.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Syndromes
Gastrointestinal
Bloodstream
Respiratory
Central Nervous System
Pneumonia

By End User
Hospitals
Diagnostics Laboratories
Research Institutes
Others

Companies

Luminex Corporation
BioFire Diagnostics
Qiagen
GenMark Diagnostics
Binx Health, Inc.
GenePOC Inc.
Janssen Global Services, LLC
Mesa Biotech
Applied BioCode, Inc.
Akonni Biosystems, Inc.
Abbott
Accelerate Diagnostics, Inc.
Alveo Technologies
Hologic, Inc.
Inflammatix, Inc.
Bosch Healthcare Solutions GmbH
Diagenode Diagnostics
Cepheid
Bio-Rad Laboratories, Inc.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.